(Other OTC:ESAUF),(CNSX:ESAU),(CNSX:ESAU.CN),(OTC US:ESAUF),(Boerse Frankfurt – Freiverkehr:Z7D), This article has been disseminated on behalf of ESGold Corp. and may include paid advertising. VANCOUVER, B.C., Nov. 13, 2025 (GLOBE NEWSWIRE) — via IBN — ESGold Corp. (CSE: ESAU | OTCQB: ESAUF | FSE: Z7D) (“ESGold” or the “Company”) is pleased to announce the partial completion and interpretation […]

(Helsinki:NOKIA),(Irish:IRSH),(LSE:0HAF),(Paris:NOKIA), Nokia CorporationStock Exchange Release13 November 2025 at 14:30 EET Directed share issuance to NVIDIA completed – a change in the total number of Nokia shares Espoo, Finland – Following the completion of the directed share issuance to NVIDIA Corporation (“NVIDIA“), announced by Nokia Corporation (“Nokia“) on 28 October 2025, a total of 166 389

Clean Label Products Market Size to Worth USD 712.48 Billion by 2034 | Towards FnB According to Towards FnB, the global clean label products market size is calculated at USD 425.32 billion in 2025 and is expected to reach USD 712.48 billion by 2034, reflecting at a CAGR of 5.9% from 2025 to 2034. This

Worksport Delivers 61% Revenue Growth and 31% Margin in Q3 2025; Positioned for 2026 Profitability with $45M+ Revenue Target GlobeNewswire November 13, 2025 2026 outlook driven by $27M-$35M in tonneau cover sales, with additional major contributions anticipated from upcoming launches of the SOLIS solar-integrated tonneau cover and COR battery system. West Seneca, New York, Nov.

LAVA Announces Exceeding Minimum Condition in Tender Offer and Intent to Delist from Nasdaq GlobeNewswire November 13, 2025 UTRECHT, The Netherlands, and PHILADELPHIA, Nov. 13, 2025 (GLOBE NEWSWIRE) — LAVA Therapeutics N.V. (“LAVA”) (Nasdaq: LVTX) today announced that 22,877,463 of LAVA's common shares, representing approximately 87% of LAVA's outstanding common shares, were validly tendered and

PharmaCorp Announces Supplemental Listing of Warrants GlobeNewswire November 13, 2025 NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES SASKATOON, Saskatchewan, Nov. 13, 2025 (GLOBE NEWSWIRE) — PharmaCorp Rx Inc. (“PharmaCorp” or the “Company”) (TSXV: PCRX) is pleased to announce that it has received approval of the TSX

Dynacor Reports Record Sales and EBITDA in Q3-2025 GlobeNewswire November 13, 2025 MONTREAL, Nov. 13, 2025 (GLOBE NEWSWIRE) — Dynacor Group Inc. (TSX: DNG) (“Dynacor” or the “Corporation”) today announced its unaudited financial and operational results1 for the third quarter ended September 30, 2025. “This was a solid third quarter that reflects our team's resolve

Danforth Health Expands Market Access Capabilities with Appointment of Beth Ann Bender and Integration of FieldQuest Payer Panel GlobeNewswire November 13, 2025 WALTHAM, Mass., Nov. 13, 2025 (GLOBE NEWSWIRE) — Danforth Health, Inc. today announced an expansion of its Market Access & Value practice with the addition of Beth Ann Bender, a seasoned expert in

FitLife Brands Announces Third Quarter 2025 Results GlobeNewswire November 13, 2025 OMAHA, NE, Nov. 13, 2025 (GLOBE NEWSWIRE) — FitLife Brands, Inc. (“FitLife” or the “Company“) (NASDAQ: FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced financial results for the third quarter ended September 30, 2025. Highlights for the third

Sagimet Biosciences Reports Third Quarter 2025 Financial Results and Provides Corporate Updates GlobeNewswire November 13, 2025 Phase 1 clinical trial to evaluate the PK of a combination of denifanstat and resmetirom ongoing with data readout expected 1H 2026 First-in-human Phase 1 clinical trial of FASN inhibitor TVB-3567 ongoing Ascletis announced completion of its pre-NDA consultation